End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.26 USD | -3.70% | -7.14% | -98.28% |
May. 14 | Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 10 | Liquidation Plan and Disclosure Statement Filed by Acorda Therapeutics, Inc. | CI |
Financials (USD)
Sales 2022 | 119M | Sales 2023 | 118M | Capitalization | 18.74M |
---|---|---|---|---|---|
Net income 2022 | -65M | Net income 2023 | -253M | EV / Sales 2022 | 1.3 x |
Net Debt 2022 | 135M | Net Debt 2023 | 161M | EV / Sales 2023 | 1.53 x |
P/E ratio 2022 |
-0.23
x | P/E ratio 2023 |
-0.07
x | Employees | 102 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.33% |
Latest transcript on Acorda Therapeutics, Inc.
1 day | -3.70% | ||
1 week | -7.14% | ||
Current month | -34.18% | ||
1 month | -40.91% | ||
3 months | -97.83% | ||
6 months | -97.95% | ||
Current year | -98.28% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 0.26 | -3.70% | 5,148 |
24-06-10 | 0.27 | -10.00% | 28,233 |
24-06-07 | 0.3 | +3.45% | 408 |
24-06-06 | 0.29 | -3.33% | 24,794 |
24-06-05 | 0.3 | +7.14% | 51,780 |
End-of-day quote OTC Markets, June 10, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-98.28% | 323K | |
+17.14% | 124B | |
+15.81% | 109B | |
-6.93% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-7.53% | 16.61B | |
-37.63% | 16.43B | |
+2.22% | 13.4B | |
+24.87% | 11.47B |
- Stock Market
- Equities
- ACOR.Q Stock